"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Receipt of the Notice of Approval for Clinical Trial of DC7001A Capsules by Wholly-owned Subsidiary Beijing Double-Crane Runchuang Technology Co., Ltd.

Announcement on Receipt of the Notice of Approval for Clinical Trial of DC7001A Capsules by Wholly-owned Subsidiary Beijing Double-Crane Runchuang Technology Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment